US 9452215
Bourvadin derivatives and therapeutic uses thereof
granted A61KA61K38/00A61K45/06
Quick answer
US patent 9452215 (Bourvadin derivatives and therapeutic uses thereof) held by The Regents of the University of Colorado expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado
- Grant date
- Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K38/00, A61K45/06